GRIFOLS -A- (GRF.MC)


MCE - MCE Delayed Price. Currency in EUR
19.10-0.10 (-0.55%)
As of 7:31 AM EDT. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open19.04
Prev Close19.20
Bid19.09 x 68800
Ask19.10 x 1500
Day's Range18.88 - 19.16
52wk Range17.85 - 46.00
1y Target EstN/A
Market CapN/A
P/E Ratio (ttm)N/A
BetaN/A
Volume396,558
Avg Vol (3m)887,740
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Investor's Business Daily3 months ago

    Zika Blood Screening Test From Hologic, Grifols Gets FDA Nod

    Diagnostics company Hologic (HOLX) and its Spanish partner Grifols (GRFS) said Monday that the FDA had granted emergency authorization for their new system for screening donated blood for the Zika virus. ...

  • Benzinga3 months ago

    Hologic And Grifols Get FDA Approval For Procleix Zika Virus Assay

    Hologic, Inc. (NASDAQ: HOLX ) and Grifols (NASDAQ: GRFS ) disclosed Monday that the U.S. Food and Drug Administration has approved use of the Procleix Zika virus blood screening assay on the Procleix Panther ...

  • Market Realist3 months ago

    Analyzing IBB’s Moving Averages

    As of June 13, 33% of IBB’s stocks were trading above their 20-day moving averages and 43% were trading above their 50-day moving averages.